Principles of immunological tolerance

Transfusion Medicine and Hemotherapy

Volumn 32, Issue 6, 2005, Pages 322-331

  Miller, Jacques F A P ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoimmunity; B cells; T cells; Thymus; Tolerance

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; BONE MARROW; CELL TYPE; CELLULAR IMMUNITY; DENDRITIC CELL; GENE DELETION; GENE SILENCING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; NATURAL KILLER CELL; NONHUMAN; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; THYMUS;

EID: 29144476515     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089119     Document Type: Review

References (85)

1. Janeway CA, Medzhitov R: Innate immune recognition. Ann Rev Immunol 2002;20:197-216.
2. Burnet FM, Fenner F: The Production of Antibodies, London, Macmillan, 1948.
3. Burnet FM: The clonal selection theory of acquired immunity Cambridge, University Press, 1959.
4. Lederberg J: Genes and antibodies: do antigens bear instructions for antibody specificity or do they select cell lines that arise by mutation? Science 1959;129:1649-1653.
5. Dresser DW, Mitchison NA: The mechanism of immunological paralysis. Adv Immunol 1968;8:129-181.
6. Sprent J, Miller JFAP: Interaction of thymus lymphocytes with histoincompatible cells. I. Quantitation of the proliferative response of thymus cells. Cell Immunol:1972;3:361-384.
7. Miller JFAP: Immunological function of the thymus. Lancet 1961;2:748-749.
8. Miller JFAP: Effect of neonatal thymectomy on the immunological responsiveness of the mouse. Proc Roy Soc London 1962;156B:415-428.
9. Goldrath AW, Bevan MJ: Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255-262.
10. Laufer TM, DeKoning J, Markowitz JS, Glimcher LH: Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 1996;383:81-85.
11. Gao JX, Huiming Z, Xue-Feng B, Jing W, Xincheng Z, Jinqing L, Pan Z, Yang L: Perinatal blockade of B7-1 and B7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J Exp Med 2002;195:959-971.
12. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S: Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454-460.
13. Strasser A, Bouillet P: The control of apoptosis in lymphocyte selection. Immunol Rev 2003;193:82-92.
14. Sprent J, Kishimoto H: The thymus and negative selection. Immunol Rev 2002;185:126-135.
15. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, Zheng L: Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Ann Rev Immunol 1999;17:221-253.
16. Liston A, Lesage S, Gray DHD, O'Reilly L, Strasser A, Fahrer AM, Boyd RL, Wilson J, Baxter AG, Gallo EM, Crabtree GR, Peng K, Wilson SR, Goodnow CC: Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 2004;21:817-830.
17. Klein L, Kyewski B: 'Promiscuous' expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity? J Mol Med 2000;78:483-494.
18. Akiyama T, Maeda S, Yamane S, Ogino K, Kasai M, Kajiura F, Matsumoto M, Inoue J: Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 2005;308:248-251.
19. Bjorses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Ellonen P, Perheentupa J, Ulmanen I, Peltonen L: Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000;66:378-392.
20. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC: Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003;4:350-354.
21. Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD: The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genetics 1997;15:293-297.
22. Chentoufi AA, Polychronakos C: Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002;51:1383-1390.
23. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C: Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 2003;111:851-857.
24. French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM: Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997;46:34-39.
25. Steptoe RJ, Ritchie JM, Harrison LC: Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest 2003; 111:1357-1363.
26. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genetics 1997;15:289-292.
27. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC: Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991;353:765-769.
28. Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R: Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004;20:785-798.
29. Nemazee D, Hogquist KA: Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr Opin Immunol 2003;15:182-189.
30. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC: Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993;72:325-335.
31. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC: Predominant autoantibody production by early human B cell precursors. Science; 2003:301:1374-1377.
32. Nossal GJV, Pike BL: Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Nat Acad Sci 1980;90:3088-3092.
33. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A: Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
34. Jun JE, Goodnow CC: Scaffolding of antigen receptors for immunogenic versus tolerogenic signalling. Nat Immunol 2003;4:1057-1064.
35. Hippen KL, Tze LE, Behrens TW: CD5 maintains tolerance in anergic B cells. J Exp Med 2000;191:883-890.
36. Wong P, Barton GM, Forbush KA, Rudensky AY: Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J Exp Med 2001;193:1179-1187.
37. Walker LS, Abbas AK: The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002;2:11-19.
38. Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-151.
39. Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, Noelle RJ, Horak I: Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 1995;25:3053-3059.
40. Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck J.M, Strauss SE, Lenardo MJ: Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999;98:47-58.
41. Marrack P, Kappler J: Control of T cell viability. Ann Rev Immunol 2004;22:765-787.
42. Barthlott T, Kassiotis G, Stockinger B: T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003;197:451-460.
43. Le Deist F, Poinsignon C, Moshous D, Fischer A, de Villartay J-P: Artemis sheds new light on V(D)J recombination. Immunol Rev 2004;200:142-155.
44. Mackay F, Schneider P, Rennert P, Browning J: BAFF and APRIL: a tutorial on B cell survival. Ann Rev Immunol 2003;21:231-264.
45. Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R: Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004;20:785-798.
46. Mackay F, Sierro F, Grey ST, Gordon TP: The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 2005;8:243-265.
47. Miller JFAP, Heath WR: Self-ignorance in the peripheral T cell pool. Immunol Rev 1993;133:131-150.
48. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976;143:1283-1288.
49. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H: Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996;184:923-930.
50. Kurts C, Kosaka H, Carbone FR, Miller JFAP, Heath WR: Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J Exp Med 1997;186:239-245.
51. Kurts C, Sutherland RM, Davey G, Li M, Lew AM, Blanas E, Carbone FR, Miller JFAP, Heath WR: CD8+ T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Nat Acad Sci 1999;96:12703-12707.
52. Davey GM, Kurts C, Miller JFAP, Bouillet P, Strasser A, Brooks AG, Carbone FR, Heath WR: Peripheral deletion of autoreactive CD8+ T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med 2002;196:947-955.
53. Heath WR, Kurts C, Miller JFAP, Carbone FR: Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 1998;187:1549-1553.
54. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Nat Acad Sci 2002;99:351-358.
55. Kurts C, Cannarile M, Klebba I, Brocker T: Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J Immunol 2001;166:1439-1442.
56. Henri S, Vremec D, Kamath A, Waithman J, Williams S, Benoist C, Burnham K, Saeland S, Handman E, Shortman K: The dendritic cell populations of mouse lymph nodes. J Immunol 2001;167:741-748.
57. Belz GT, Behrens GM, Smith CM, Miller JFAP, Jones C, Lejon K, Fathman CG, Mueller SN, Shortman K, Carbone FR, Heath WR: The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002;196:1099-1104.
58. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, Glaichenhaus N: Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 2002;16:169-181.
59. den Haan JM, Lehar SM, Bevan MJ: CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells In vivo. J Exp Med 2000;192:1685-1696.
60. Smith CM, Belz GT, Wilson NS, Villadangos JA, Shortman K, Carbone FR, Heath WR: Cutting Edge: conventional CD8α+ dendritic cells are preferentially involved in CTL priming after footpad infection with Herpes simplex virus-1. J Immunol 2003;170:4437-4440.
61. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, Carbone FR: Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science 2003;301:1925-1928.
62. Matzinger P: Tolerance, danger and the extended family. Ann Rev Immunol 1994;12:991-1045.
63. Brent L, Medawar PB, Sparrow EM: Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proc Roy Soc London 1954;143B:43-58.
64. Billingham RE, Brent L, Medawar PB: Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Phil Trans Roy Soc London 1956;2398:357-412.
65. Le Douarin N, Corbel C, Bandeira A, Thomas-Vaslin V, Modigliani Y, Coutinho A, Salaun J: Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev 1996;149:35-53.
66. Saoudi A, Seddon B, Heath V, Fowell D, Mason D: The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 1996;149:195-216.
67. Gershon RK: T-cell control of antibody production. Contemp Topics Immunobiol 1974;3:1-40.
68. Nishizuka Y, Sakahura T: Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969;166:753-755.
69. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune response. Ann Rev Immunol 2004;22:531-562.
70. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
71. Fontenot JD, Rasmussen JF, Williams LM, Dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005;22:329-341.
72. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
73. low) CD4+ T cells. J Exp Med 1996;183:2669-2674.
74. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ: Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004;21:589-601.
75. Malek TR, Yu A, Vincek V, Scibelli P, Kong L: CD4 regulatory T cells prevent lethal autoimmunity in IL-2R-deficient mice: implications for the nonredundant function of IL-2. Immunity 2002;17:167-178.
76. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-21.
77. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko S-A, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73.
78. Bendelac A, Rivera MN, Park SH, Roark JH: Mouse CD1-specific NK1T cells: development, specificity and function. Ann Rev Immunol 1997;15:535-562.
79. Kinjo Y, Wu D, Kim G, Xing G-W, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong C-H, Kronenberg M: Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005;434:520-525.
80. Godfrey DI, Kronenberg M: Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004;114:1379-1388.
81. van der Vliet HJ, Molling JW, von Blomberg BM, Nishi N, Kolgen W, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ: The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol 2004;112:8-23.
82. Arnold B, Schonrich G, Hammerling GJ: Multiple levels of peripheral tolerance. Immunol Today 1993;14:12-14.
83. Rogers PR, Matsumoto A, Naidenko O, Kronenberg M, Mikayama T, Kato S: Expansion of human V24+ NKT cells by repeated stimulation with KRN7000. J Immunol Meth 2004;285:197-214.
84. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-1465.
85. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953;172:603-606.